The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.99.0% Purity Segment to Reach $ Million by 2030, with a % CAGR in next six years.The global key manufacturers of 1-Butyl-3-methylimidazolium Bromide include Changzhou Chongkai Chemical, Shandong DYCK Biotech, Henan Lihua Pharmaceutical and Jinkai Chemical, etc. in 2023, the global top five players have ..